48 results on '"Haller, Stephanie"'
Search Results
2. Data from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
3. Supplementary Materials and Methods from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
4. Supplementary Figures 1 through 8 from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
5. Supplementary Tables 1 and 2 from 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
6. Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors
7. 47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
8. Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy
9. Cyclotron production of 44Sc: From bench to bedside
10. Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate
11. Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
12. Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
13. 18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study
14. 18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study
15. F-18-AzaFol for Detection of Folate Receptor-beta Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study
16. Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2
17. Expression of the Rh-Related Glycoprotein (Rh50)
18. Imaging quality of 44Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET
19. A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice
20. Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties
21. Radiofolates and Radiopeptides: Exploration of Radionuclide Therapies towards Reduced Renal Side Effects
22. Cyclotron production of 44Sc: From bench to bedside
23. Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2.
24. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18
25. Investigation of the chick embryo as a potential alternative to the mouse for evaluation of radiopharmaceuticals
26. Preclinical application of 47Sc-folate – A pilot study in tumor-bearing mice
27. Sc as useful β-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes.
28. Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice
29. Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice
30. Folate Receptor Targeted Alpha-Therapy Using Terbium-149
31. 177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
32. Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
33. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18.
34. Expression Profiles of Metabolic Enzymes and Drug Transporters in the Liver and along the Intestine of Beagle Dogs
35. Erratum: Genomics drugs in clinical trials
36. Genomics drugs in clinical trials
37. Hylan G-F 20 Improves Hip Osteoarthritis: A Prospective, Randomized Study
38. Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice.
39. Direct in vitro and in vivo comparison of Tb and Lu using a tumour-targeting folate conjugate.
40. Use of RhD Fusion Protein Expressed on K562 Cell Surface in the Study of Molecular Basis for D Antigenic Epitopes
41. Additional file 1: Figure S1a. of 47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
42. A short-term biological indicator for long-term kidney damage after radionuclide therapy in mice
43. Folate Receptor Targeted Alpha-Therapy Using Terbium-149
44. Folate receptor targeted alpha-therapy using terbium-149
45. Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate
46. Additional file 1: Figure S1a. of 47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
47. Genomics drugs in clinical trials.
48. 18 F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.